Metastatic gastric cancer traditionally hinders surgical treatment options, confining them to
palliative procedures. The presence of metastases in these tumors is classified as M1 …

BACKGROUND: Even in clinical stage IV gastric cancer (GC), surgical procedures may be
required to palliate symptoms or in an attempt to improve survival. However, the limited …

OBJECTIVE: The Coronavirus Disease 2019 (COVID-19) pandemic has been recognized as
one of the most serious public health crises. This study aimed to evaluate the short-term …

ABSTRACT BACKGROUND: Peritoneal carcinomatosis in gastric cancer is considered a
fatal disease, without expectation of definitive cure. As systemic chemotherapy is not …

ABSTRACT BACKGROUND: Surgical resection remains the main curative therapeutic
modality for advanced gastric cancer. Recently, the association of preoperative …

ABSTRACT BACKGROUND: The main treatment modality for gastric cancer is surgical
resection with lymphadenectomy. Despite advances in perioperative care, major surgical …

Objective Remnant gastric cancer (RGC) is usually associated with a worse prognosis. As
they are less common and very heterogeneous tumors, new prognostic and reliable …

ABSTRACT BACKGROUND: Hematological recurrence is the second most frequent cause
of failure in the treatment of gastric cancer. The detection of circulating tumor markers in …

ABSTRACT BACKGROUND: Gastric cancer is an aggressive neoplasm with a poor
prognosis. The multimodal approach with perioperative chemotherapy is currently the …

ABSTRACT BACKGROUND: Gastric neuroendocrine tumors are a heterogeneous group of
neoplasms that produce bioactive substances. Their treatment varies according to staging …